Preventing a Second Stroke in the Young

REFERENCES

• Kittner Si. Stroke in the young: coming of age. Neurology. 2002;59(1):6–7.
   PubMed Web of Science ®Google Scholar
• Cardiovascular Disease Surveillance, Stroke. 191980-1989 Atlanta, GA: Center for Disease Control; 1994.
   Google Scholar
• Leys D, et al. Clinical outcome in 287 consecutive young adults (15 to 45 years) with ischemic stroke. Neurology. 2002;59(1):26–33.
   PubMed Web of Science ®Google Scholar
• Marini C, Carolei A. Epidemiology of stroke in the young. Stroke. 2003;34(5):13; author reply e13.
   Google Scholar
• Kristensen B, et al. Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke. 1997;28(9):1702–1709.
   PubMed Web of Science ®Google Scholar
• Kittner Si, et al. Cerebral infarction in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Neurology. 1998;50(4):890–894.
   PubMed Web of Science ®Google Scholar
• Adams HP Jr, et al. Ischemic stroke in young adults. Experience in 329 patients enrolled in the Iowa Registry of stroke in young adults. Arch Neurol. 1995;52(5):491–495.
   PubMed Web of Science ®Google Scholar
• Kappelle LJ, et al. Prognosis of young adults with ischemic stroke. A long-term follow-up study assessing recurrent vascular events and functional outcome in the Iowa Registry of Stroke in Young Adults. Stroke. 1994;25(7):1360–1365.
   PubMed Web of Science ®Google Scholar
• Petty GW, et al. Ischemic stroke subtypes: a popu-lation-based study of incidence and risk factors. Stroke. 1999;30(12):2513–2516.
   PubMed Web of Science ®Google Scholar
• Petty GW, et al. Patent foramen ovale in patients with cerebral infarction. A transesophageal echocar-diographic study. Arch Neurol. 1997;54(7):819–822.
   PubMed Web of Science ®Google Scholar
• Petty GW, et al. Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology. 1998;50(1):208–216.
   PubMed Web of Science ®Google Scholar
• Petty GW, et al. Ischemic stroke subtypes: a popu-lation-based study of functional outcome, survival, and recurrence. Stroke. 2000;31(5):1062–1068.
   PubMed Web of Science ®Google Scholar
• Yonemura K, et al. [Analysis of ischemic stroke in patients aged up to 50 years]. Rinsho Shinkeigaku. 2000;40(9):881–886.
   PubMedGoogle Scholar
• Kittner Si, et al. Black-white differences in stroke risk among young adults. Stroke. 1993;24(12 sup-pl): 113-15; discussion 120–21.
   Google Scholar
• Giles WH, et al. Determinants of black-white differ-ences in the risk of cerebral infarction. The National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Arch Intern Med. 1995;155(12):1319–1324.
   PubMed Web of Science ®Google Scholar
• Kase CS, et al. Prevalence of silent stroke in patients presenting with initial stroke: the Framingham Study. Stroke. 1989;20(7):850–852.
   PubMed Web of Science ®Google Scholar
• Liao D, et al. Presence and severity of cerebral white matter lesions and hypertension, its treat-ment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke. 1996;27(12):2262–2270.
   PubMedGoogle Scholar
• MacMahon S, Rodgers A. Blood pressure, antihy-pertensive treatment and stroke risk. J Hypertens Suppl. 1994;12(10):S5–14.
   PubMedGoogle Scholar
• Higgins M, Thom T. Trends in stroke risk factors in the United States. Ann Epidemiol. 1993;3(5): 550–554.
   PubMedGoogle Scholar
• Thom Ti. Stroke mortality trends. An international perspective. Ann Epidemiol. 1993;3(5):509–518.
   PubMedGoogle Scholar
• Chobanian AV, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the J NC 7 report. 'AMA. 2003;289(19):2560–2572.
   PubMed Web of Science ®Google Scholar
• Major outcomes in moderately hypercholes-terolemic, hypertensive patients randomized to pravastatin vs. usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). ]AMA. 2002;288(23):2998–3007.
   PubMed Web of Science ®Google Scholar
• Yusuf S, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl ] Med. 2000;342(3):145–153.
   PubMed Web of Science ®Google Scholar
• Fox K. The EUROPA trial. Lancet. 2003;362(9399): 1936–1937.
   PubMed Web of Science ®Google Scholar
• Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individu-als with previous stroke or transient ischaemic attack. Lancet. 2001;358(9287):1033–1041.
   PubMed Web of Science ®Google Scholar
• Wolf PA, et al. Cigarette smoking as a risk factor for stroke. The Framingham Study. ]AMA. 1988; 259(7):1025–1029.
   PubMed Web of Science ®Google Scholar
• Kurth T, et al. Smoking and risk of hemorrhagic stroke in women. Stroke. 2003;34(12):2792–2795.
   PubMed Web of Science ®Google Scholar
• Kawachi I, et al. Smoking cessation and decreased risk of stroke in women. ]AMA. 1993;269(2): 232–236.
   PubMed Web of Science ®Google Scholar
• Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BM]. 1989;298(6676):789–794.
   PubMed Web of Science ®Google Scholar
• Sacco RL, et al. American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke. 1997;28(7):1507–1517.
   PubMed Web of Science ®Google Scholar
• Heiss G, et al. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am] Epidemiol. 1991;134(3):250–256.
   PubMed Web of Science ®Google Scholar
• Espeland MA, et al. Reliability of longitudinal ultra-sonographic measurements of carotid intimal-medial thicknesses. Asymptomatic Carotid Artery Progression Study Research Group. Stroke. 1996;27(3):480–485.
   PubMed Web of Science ®Google Scholar
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344(8934):1383–1389.
   PubMed Web of Science ®Google Scholar
• Byington RP, et al. Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation. 1995;92(9):2419–2425.
   PubMed Web of Science ®Google Scholar
• Bucher HC, Griffith LE, Guyatt GH. Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials. Ann Intern Med. 1998;128(2):89–95.
   PubMed Web of Science ®Google Scholar
• Hebert PR, et al. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. ]AMA. 1997;278(4): 313–321.
   PubMed Web of Science ®Google Scholar
• Eidelman RS, Lamas GA, Hennekens CH. The new National Cholesterol Education Program guidelines: clinical challenges for more widespread therapy of lipids to treat and prevent coronary heart disease. Arch Intern Med. 2002;162(18):2033–2036.
   PubMed Web of Science ®Google Scholar
• Hennekens C. Risk factor reduction (secondary prevention) of cardiovascular disease and stroke. Up to Date. 2002.
   Google Scholar
• Rauoof MA, et al. Measurement of plasma lipids in patients admitted with acute myocardial infarction or unstable angina pectoris. Am ] Cardiol. 2001; 88(2):165–167, AS.
   PubMed Web of Science ®Google Scholar
• Burchfiel CM, et al. Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program. Stroke. 1994;25(5):951–957.
   PubMed Web of Science ®Google Scholar
• De Courten-Myers GM, Myers RE, Wagner KR. Effect of hyperglycemia on infarct size after cerebrovascu-lar occlusion in cats. Stroke. 1989;20(4):519–523.
   PubMedGoogle Scholar
• De Courten-Mayers GM, Kleinholz M, Wagner KR, Myers RE. Determiners of fatal reperfusion brain oedema. Acta Neurochirurgica. 1990;51:226–229.
   Google Scholar
• Intensive blood-glucose control with sulphony-lureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352:837.
   PubMed Web of Science ®Google Scholar
• Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am I Cardiol. 1995;75:894.
   Google Scholar
• Nesto RW. The relation of insulin resistance syn-dromes to risk of cardiovascular disease. Rev Cardiovasc Med. 2003;4\(suppl 6):11–18.
   Google Scholar
• Gray CS, Taylor R, French IM, et al. The prognostic value of stress hyperglycemia and previously unrecognized diabetes mellitus in acute stroke. Diabet Med. 1987;4:237–240.
   PubMed Web of Science ®Google Scholar
• Weir GI, Murray GD, Dyker, AG, Lees KR. Is hyper-glycaemia an independent predictor of poor out-come after acute stroke? Results of a long term fol-low up study. BM]. 1997;314:1303–1306.
   PubMed Web of Science ®Google Scholar
• Riddle MC, Hart J. Hyperglycemia, recognized and unrecognized, as a risk factor for stroke and tran-sient ischemic attacks. Stroke. 1982;13:356–359.
   PubMed Web of Science ®Google Scholar
• Oppenheimer SM, Hoffbrand B, Oswald GA, Yudkin IS. Diabetes mellitus and early mortality from stroke. BM]. 1985;291:1014–1015.
   PubMed Web of Science ®Google Scholar
• Gray, CS, Hildreth, AJ, Alberti GKMM, O'Connell, JE, on behalf of the FIST Collaboration. Poststroke hyperglycemia - natural history and immediate management. Stroke. 2004;35:122–126.
   PubMed Web of Science ®Google Scholar
• Morris SL, Nichols PJ, Caspersen CJ, et al. Increasing diabetes self-management education in community settings. A systematic review. Am] Prey Med. 2002:22\(suppl 4):39–66.
   PubMed Web of Science ®Google Scholar
• Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investiga-tion of cancer and nutrition (EPIC-Norfolk). BM]. 2001;322:15.
   PubMed Web of Science ®Google Scholar
• McCully KS. Vascular pathology of homocysteine-mia: implications for the pathogenesis of arte-riosclerosis. Am] Pathol. 1969;56(1):111–128.
   PubMed Web of Science ®Google Scholar
• Fowler B. Disorders of homocysteine metabolism. ] Inherit Metab Dis. 1997;20(2):270–285.
   PubMed Web of Science ®Google Scholar
• Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl ] Med. 1998;338(15): 1042–1050.
   PubMed Web of Science ®Google Scholar
• Welch GN, Upchurch G Jr, Loscalzo J. Hyperhomocyst(e)inemia and atherothrombosis. Ann NY Acad Sci. 1997;811:48-58; discussion 58–59.
   PubMed Web of Science ®Google Scholar
• Boers GH, et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl I Med. 1985;313(12): 709–715.
   PubMed Web of Science ®Google Scholar
• Clarke R, et al. Hyperhomocysteinemia: an inde-pendent risk factor for vascular disease. N Engl I Med. 1991;324(17):1149–1155.
   PubMed Web of Science ®Google Scholar
• Brattstrom LE, Hardebo JE, Hultberg BL. Moderate homocysteinemia-a possible risk factor for arte-riosclerotic cerebrovascular disease. Stroke. 1984;15(6):1012–1016.
   PubMed Web of Science ®Google Scholar
• Araki A, et al. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis. 1989;79(2-3):139–146.
   PubMed Web of Science ®Google Scholar
• Coull BM, et al. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke. 1990;21(4):572–576.
   PubMed Web of Science ®Google Scholar
• Brattstrom L, et al. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur I Clin Invest. 1992;22(3):214–221.
   PubMed Web of Science ®Google Scholar
• Alfthan G, et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerot-ic disease in a prospective Finnish population based study. Atherosclerosis. 1994;106(1):9–19.
   PubMed Web of Science ®Google Scholar
• Verhoef P, et al. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke. 1994;25(10):1924–1930.
   PubMed Web of Science ®Google Scholar
• Perry lb et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 1995;346(8987): 1395–1398.
   PubMed Web of Science ®Google Scholar
• Selhub J, et al. Association between plasma homo-cysteine concentrations and extracranial carotid-artery stenosis. N Engl I Med. 1995;332(5): 286–291.
   PubMed Web of Science ®Google Scholar
• Bostom AG, et al. Nonfasting plasma total homocys-teine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med. 1999;159(10):1077–1080.
   PubMed Web of Science ®Google Scholar
• Malinow MR, et al. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. Circulation. 1993;87(4): 1107–1113.
   PubMed Web of Science ®Google Scholar
• Bots ML, et al. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. Arch Intern Med. 1999;159(1): 38–44.
   PubMed Web of Science ®Google Scholar
• Kittner SJ, et al. Homocyst(e)ine and risk of cerebral infarction in a biracial population: the stroke pre-vention in young women study. Stroke. 1999;30(8): 1554–1560.
   PubMed Web of Science ®Google Scholar
• Yoo JFI, Chung CS, Kang SS. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. Stroke. 1998;29(12):2478–2483.
   PubMed Web of Science ®Google Scholar
• Lamy C, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke. 2002;33(3):706–711.
   PubMed Web of Science ®Google Scholar
• Mas IL. Patent foramen ovale, atrial septal aneurysm and ischaemic stroke in young adults. Eur Heart]. 1994;15(4):446–449.
   PubMed Web of Science ®Google Scholar
• Mas IL. Diagnosis and management of paradoxical embolism and patent formen ovale. Curr Opin Cardiol. 1996;11 (5):519–524 .
   PubMed Web of Science ®Google Scholar
• Mas IL, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345(24): 1740–1746.
   PubMed Web of Science ®Google Scholar
• Mas IL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or tran-sient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart]. 1995;130(5):1083–1088.
   PubMed Web of Science ®Google Scholar
• Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17–20.
   Google Scholar
• Arquizan C, et al. Is patent foramen ovale a family trait? A transcranial Doppler sonographic study. Stroke. 2001;32(7):1563–1566.
   PubMed Web of Science ®Google Scholar
• Cabanes L, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke. 1993; 24(12):1865–1873.
   PubMed Web of Science ®Google Scholar
• Lechat P, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988; 318(18):1148–1152.
   PubMed Web of Science ®Google Scholar
• Di Tullio M, et al. Patent foramen ovale as a risk fac-tor for cryptogenic stroke. Ann Intern Med. 1992; 117(6):461–465.
   PubMed Web of Science ®Google Scholar
• Cabanes L, et al. Interobserver and intraobserver variability in detection of patent foramen ovale and atrial septal aneurysm with transesophageal echocardiography. J Am Soc Echocardiogr. 2002; 15(5):441–446.
   PubMed Web of Science ®Google Scholar
• Rodriguez CJ, Homma S. Hypercoagulable states in patients with patent foramen ovale. Curr Hematol Rep. 2003;2(5):435–441.
   PubMedGoogle Scholar
• Cramer SC, et al. Paradoxical emboli from calf and pelvic veins in cryptogenic stroke. J Neuroimaging. 2003;13(3):218–223.
   PubMed Web of Science ®Google Scholar
• Cramer SC, et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke. 2004;35(1):46–50.
   PubMed Web of Science ®Google Scholar
• Sloan MA, et al. Illicit drug-associated ischemic stroke in the Baltimore-Washington Young Stroke Study. Neurology. 1998;50(6):1688–1693.
   PubMed Web of Science ®Google Scholar
• Kaku DA, Lowenstein DH. Emergence of recreational drug abuse as a major risk factor for stroke in young adults. Ann Intern Med. 1990;113(11):821–827.
   PubMed Web of Science ®Google Scholar
• Kernan WN, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 2000;343(25):1826–1832.
   PubMed Web of Science ®Google Scholar
• Cantu C, Arauz A, Murillo-Bonilla LM, Lopez M, Barinagarrementeria F. Stroke associated with sym-pathomimetics contained in over-the-counter cough and cold drugs. Stroke. 2003;34(7):1667–1672.
   PubMed Web of Science ®Google Scholar
• Kelly MA, Gorelick PB, Mirza D. The role of drugs in the etiology of stroke. Clin Neuropharmacol. 1992;15(4):249–275.
   PubMed Web of Science ®Google Scholar
• Goldberg II, et al. AHA Science Advisory: wine and your heart: a science advisory for healthcare pro-fessionals from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association. Circulation. 2001;103(3):472–475.
   PubMed Web of Science ®Google Scholar
• Camargo CA Jr. Moderate alcohol consumption and stroke. The epidemiologic evidence. Stroke. 1989;20(12):1611–1626.
   PubMed Web of Science ®Google Scholar
• Sacco RL, et al. The protective effect of moderate alcohol consumption on ischemic stroke. /AMA. 1999;281 (1):53–60.
   PubMed Web of Science ®Google Scholar
• Berger K, et al. Light-to-moderate alcohol con-sumption and risk of stroke among U.S. male physi-cians. N Engl J Med. 1999;341(21):1557–1564.
   PubMed Web of Science ®Google Scholar
• Hart CL, et al. Alcohol consumption and mortality from all causes, coronary heart disease, and stroke: results from a prospective cohort study of Scottish men with 21 years of follow up. BM]. 1999; 318(7200):1725–1729.
   PubMed Web of Science ®Google Scholar
• Djousse L, et al. Alcohol consumption and risk of ischemic stroke: The Framingham Study. Stroke. 2002;33(4):907–912.
   PubMed Web of Science ®Google Scholar
• Reynolds K, et al. Alcohol consumption and risk of stroke: a meta-analysis. /AMA. 2003;289(5): 579–588.
   PubMed Web of Science ®Google Scholar
• Klatsky AL, Friedman GD, Armstrong MA. The rela-tionships between alcoholic beverage use and oth-er traits to blood pressure: a new Kaiser Permanente study. Circulation. 1986;73(4):628–636.
   PubMed Web of Science ®Google Scholar
• Tjonneland A, et al. Lifetime alcohol consumption and postmenopausal breast cancer rate in Denmark: a prospective cohort study. I Nutr. 2004; 134(1):173–178.
   PubMed Web of Science ®Google Scholar
• Longnecker MR Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control. 1994;5(1):73–82.
   PubMed Web of Science ®Google Scholar
• Smith-Warner SA, et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. /AMA. 1998;279(7):535–540.
   PubMed Web of Science ®Google Scholar
• Beckmann CRB, Ling F, Herbert WNP, Laube DW, Smith RP, Barzansky BM. Obstetrics and Gynecology. Baltimore: Williams & Wilkins; 1998.
   Google Scholar
• Heinemann LA, et al. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women. BM]. 1997;315(7121):1502–1504.
   PubMed Web of Science ®Google Scholar
• Petitti DB, et al. Stroke in users of low-dose oral contraceptives. N Engl I Med. 1996;335(1):8–15.
   PubMed Web of Science ®Google Scholar
• Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives: a meta-analy-sis. /AMA. 2000;284(1):72–78.
   PubMed Web of Science ®Google Scholar
• Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet. 1995;346(8990): 1582–1588.
   PubMedGoogle Scholar
• Schwartz SM, et al. Use of low-dose oral contra-ceptives and stroke in young women. Ann Intern Med. 1997;127(8 Pt 1):596–603.
   PubMed Web of Science ®Google Scholar
• Chasan-Taber L, et al. Prospective study of oral con-traceptives and hypertension among women in the United States. Circulation. 1996;94(3):483–489.
   PubMed Web of Science ®Google Scholar
• Lidegaard O. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influ-ence of diabetes, hypertension, migraine and pre-vious thrombotic disease. Br I Obstet Gynaecol. 1995;102(2):153–159.
   PubMedGoogle Scholar
• Musolino R, et al. Ischaemic stroke in young peo-ple: a prospective and long-term follow-up study. Cerebrovasc Dis. 2003;15(1-2):121–128.
   PubMed Web of Science ®Google Scholar
• Tzourio C, et al. Case-control study of migraine and risk of ischaemic stroke in young women. BM]. 1995;310(6983):830–833.
   PubMed Web of Science ®Google Scholar
• Carolei A, Marini C, De Matteis G. History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet. 1996;347(9014):1503–1506.
   PubMed Web of Science ®Google Scholar
• Henrich JB, Horwitz RI. A controlled study of ischemic stroke risk in migraine patients. I Clin Epidemiol. 1989;42(8):773–780.
   PubMed Web of Science ®Google Scholar
• Merikangas KR, et al. Association between migraine and stroke in a large-scale epidemiologi-cal study of the United States. Arch Neurol. 1997;54(4):362–368.
   PubMed Web of Science ®Google Scholar
• Morandi E, et al. Transcatheter closure of patent foramen ovale: a new migraine treatment? I Interv Cardiol. 2003;16(1):39–42.
   PubMedGoogle Scholar
• Onorato E, et al. Patent foramen ovale with para-doxical embolism: mid-term results of tran-scatheter closure in 256 patients. I Interv Cardiol. 2003;16(1):43–50.
   PubMedGoogle Scholar
• Kittner SJ, et al. Pregnancy and the risk of stroke. N Engl I Med. 1996;335(11):768–774.
   PubMed Web of Science ®Google Scholar
• Pathan M, Kittner SJ. Pregnancy and stroke. Curr Neurol Neurosci Rep. 2003;3(1):27–31.
   PubMedGoogle Scholar
• Leys D, et al. Arterial ischemic strokes associated with pregnancy and puerperium. Acta Neurol Be/g. 1997;97(1):5–16.
   PubMed Web of Science ®Google Scholar